This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08997/identifier/drugbank/

Statements

Subject Item
n2:DB08997
rdf:type
n3:Drug
n3:description
A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
n3:group
withdrawn
owl:sameAs
n6:DB08997
dcterms:title
Dexetimide
adms:identifier
n8:DB08997
n3:synthesisReference
U.S. Patent 3,125,578.
n3:IUPAC-Name
n4:271B6365-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B636B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B636A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6367-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6368-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6369-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6363-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6361-363D-11E5-9242-09173F13E4C5 n4:271B6364-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6362-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6371-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6372-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B636C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B636D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B636F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B636E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6370-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
21888-98-2
n3:Bioavailability
n4:271B6377-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6379-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B637A-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B637B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6376-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6375-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6378-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6366-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6373-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6374-363D-11E5-9242-09173F13E4C5